Home » Topics » BioWorld Science

BioWorld Science
RSS

Nisin in testing for Helicobacter infections

April 12, 1996

Improved Havrix approved by FDA

April 12, 1996

OraVax granted patent on H. pylori vaccine technology

April 12, 1996

Novel prostaglandin D2 agonists from Glaxo Wellcome

April 12, 1996

XR-300 fibrinogen antagonist in preclinical testing

April 12, 1996

Merck & Co. describes fibrinogen antagonists

April 12, 1996

Fibrinogen antagonists from Yamanouchi

April 12, 1996

ATIII in development at Genzyme Transgenics

April 12, 1996

Neutralase to enter phase II

April 12, 1996

YM-087 in phase I for CHF

April 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...